Drug Trial Radar · NCT02309762
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of FB825 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Feb 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Mar 2015
Primary completion
Feb 2016
Study completion Feb 2016
Sponsor
- Lead sponsor
- Fountain Biopharma Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 5, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of single-ascending IV doses of FB825
Conditions
- Healthy
Interventions
FB825Drug
FB825 will be supplied at a concentration of 20 mg/mL for a single dose IV injection
PlaceboDrug
Solution containing no active ingredients
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Adverse events (AE)Time frame: Up to day140
- Clinical laboratory test results (hematology, coagulation, serum chemistry[including liver function tests], and urinalysis)Time frame: Up to day140
- Vital sign measurements (systolic and diastolic blood pressures, heart rate, respiratory rate, and oral body temperature)Time frame: Up to day140
- 12-lead ECG resultsTime frame: Up to day140
- Physical examination findingsTime frame: Up to day140
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.